Patents by Inventor Marina Brockway

Marina Brockway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9314181
    Abstract: Aspects of the present disclosure are directed to detecting Atrial Fibrillation (AF). As may be implemented in accordance with one or more embodiments, a time series of inter-beat intervals is computed from a recording of activity of a beating heart. The time series is decomposed into subcomponents, and an envelope of at least one of the subcomponents is computed. The presence of atrial fibrillation (AF) is detected based upon characteristics of the envelope that are indicative of AF.
    Type: Grant
    Filed: February 25, 2015
    Date of Patent: April 19, 2016
    Assignee: VivaQuant LLC
    Inventors: Marina Brockway, Brian Brockway
  • Patent number: 9294074
    Abstract: Physiological signals are denoised. In accordance with an example embodiment, a denoised physiological signal is generated from an input signal including a desired physiological signal and noise. The input signal is decomposed from a first domain into subcomponents in a second domain of higher dimension than the first domain. Target subcomponents of the input signal that are associated with the desired physiological signal are identified, based upon the spatial distribution of the subcomponents. A denoised physiological signal is constructed in the first domain from at least one of the identified target subcomponents.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: March 22, 2016
    Assignee: VivaQuant LLC
    Inventor: Marina Brockway
  • Publication number: 20160022164
    Abstract: Various aspects are directed to identifying a region of interest in a physiological signal. As may be consistent with one or more embodiments, the physiological signal is decomposed into subcomponents, and a subset of the subcomponents is selected based upon overlap of spectral energy with expected spectral energy of the region of interest, in at least one of the subcomponents. At least two of the subcomponents in the subset are combined and compared to a threshold, with the comparison being used to identify the location of the region of interest.
    Type: Application
    Filed: August 4, 2015
    Publication date: January 28, 2016
    Inventors: Marina Brockway, Brian Brockway
  • Patent number: 9072438
    Abstract: A cardiac-based metric is computed based upon characteristics of a subject's cardiac function. In accordance with one or more embodiments, the end of a mechanical systole is identified for each of a plurality of cardiac cycles of a subject, based upon an acoustical vibration associated with closure of an aortic valve during the cardiac cycle. The end of an electrical systole of an electrocardiogram (ECG) signal for each cardiac cycle is also identified. A cardiac-based metric is computed, based upon a time difference between the end of the electrical systole and the end of the mechanical systole, for the respective cardiac cycles.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: July 7, 2015
    Assignee: VivaQuant LLC
    Inventors: Marina Brockway, Brian Brockway, Robert Hamlin
  • Publication number: 20150164355
    Abstract: Aspects of the present disclosure are directed to detecting Atrial Fibrillation (AF). As may be implemented in accordance with one or more embodiments, a time series of inter-beat intervals is computed from a recording of activity of a beating heart. The time series is decomposed into subcomponents, and an envelope of at least one of the subcomponents is computed. The presence of atrial fibrillation (AF) is detected based upon characteristics of the envelope that are indicative of AF.
    Type: Application
    Filed: February 25, 2015
    Publication date: June 18, 2015
    Inventors: Marina Brockway, Brian Brockway
  • Patent number: 9050007
    Abstract: A T-wave offset point of an ECG signal is provided. In accordance with various example embodiments, a location of a QRS complex in the ECG signal is identified and used to determine a first time window of the ECG signal in which to search for a T-wave offset point. The T-wave offset point is identified within the first time window, and the identified T-wave offset point is provided as an output based upon a noise characteristic of the ECG signal in a second time window that includes at least a portion of the T-wave.
    Type: Grant
    Filed: April 29, 2013
    Date of Patent: June 9, 2015
    Assignee: VivaQuant LLC
    Inventors: Marina Brockway, Brian Brockway
  • Patent number: 9008762
    Abstract: A cardiac-based metric is computed based upon characteristics of a subject's cardiac function. In accordance with one or more embodiments, the end of a mechanical systole is identified for each of a plurality of cardiac cycles of a subject, based upon an acoustical vibration associated with closure of an aortic valve during the cardiac cycle. The end of an electrical systole of an electrocardiogram (ECG) signal for each cardiac cycle is also identified. A cardiac-based metric is computed, based upon a time difference between the end of the electrical systole and the end of the mechanical systole, for the respective cardiac cycles.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: April 14, 2015
    Assignee: VivaQuant LLC
    Inventors: Marina Brockway, Brian Brockway
  • Publication number: 20140364756
    Abstract: Aspects of the present disclosure are directed to processing ECG signals from a subject. As may be implemented in accordance with one or more embodiments, respective electrodes sense ECG signals from a subject, and the ECG signals are digitized and processed, such as to remove noise, detect a QRS complex, evaluate quality, detect arrhythmia and/or to store the signals. In response to an input from the subject, one or more of the ECG signals is recorded along with sound from the user, such as to concurrently record the user's voice for describing conditions in connection with the recording of the ECG signals. This approach can be carried out in an enclosed housing, operated adjacent the subject's thorax. The processed digitized ECG signals and the audio signals are then communicated for receipt by an external device.
    Type: Application
    Filed: August 25, 2014
    Publication date: December 11, 2014
    Inventors: BRIAN BROCKWAY, MARINA BROCKWAY
  • Patent number: 8905938
    Abstract: Implantable medical devices and techniques are implemented that use bio-impedance to measure aspects of patient physiology. A signal separation method is performed at least in part in an implantable device. The method involves detecting a plurality of impedance signals using a plurality of implantable electrodes coupled to the implantable device. The method further involves separating one or more signals from the plurality of impedance signals using a signal separation technique, such as an algorithm-based separation technique.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: December 9, 2014
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: John D. Hatlestad, Marina Brockway, Yousufali Husaini Dalal, Loell Boyce Moon
  • Publication number: 20140296726
    Abstract: A cardiac-based metric is computed based upon characteristics of a subject's cardiac function. In accordance with one or more embodiments, the end of a mechanical systole is identified for each of a plurality of cardiac cycles of a subject, based upon an acoustical vibration associated with closure of an aortic valve during the cardiac cycle. The end of an electrical systole of an electrocardiogram (ECG) signal for each cardiac cycle is also identified. A cardiac-based metric is computed, based upon a time difference between the end of the electrical systole and the end of the mechanical systole, for the respective cardiac cycles.
    Type: Application
    Filed: June 16, 2014
    Publication date: October 2, 2014
    Inventors: MARINA BROCKWAY, BRIAN BROCKWAY
  • Patent number: 8843196
    Abstract: Cardiac systems and methods using ECG and blood information for arrhythmia detection and discrimination. Detection circuitry is configured to produce an ECG. An implantable blood sensor configured to produce a blood sensor signal is coupled to a processor. The processor is coupled to the detection and energy delivery circuitry, and used to evaluate and treat cardiac rhythms using both the cardiac electrophysiologic and blood sensor signals. The blood sensor is configured for subcutaneous non-intrathoracic placement and provided in or on the housing, on a lead coupled to the housing, and/or separate to the housing and coupled to the processor via hardwire or wireless link. The blood sensor may be configured for optical sensing, using a blood oxygen saturation sensor or pulse oximeter. A cardiac rhythm may be evaluated using the electrocardiogram signal and the blood sensor signal, and tachyarrhythmias may be treated after confirmation using the blood sense signal.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: September 23, 2014
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Apurv Kamath, Paul Haefner, Darrell O. Wagner, Marina Brockway
  • Publication number: 20140213921
    Abstract: A cardiac-based metric is computed based upon characteristics of a subject's cardiac function. In accordance with one or more embodiments, the end of a mechanical systole is identified for each of a plurality of cardiac cycles of a subject, based upon an acoustical vibration associated with closure of an aortic valve during the cardiac cycle. The end of an electrical systole of an electrocardiogram (ECG) signal for each cardiac cycle is also identified. A cardiac-based metric is computed, based upon a time difference between the end of the electrical systole and the end of the mechanical systole, for the respective cardiac cycles.
    Type: Application
    Filed: March 31, 2014
    Publication date: July 31, 2014
    Applicant: VivaQuant LLC
    Inventors: MARINA BROCKWAY, BRIAN BROCKWAY, ROBERT HAMLIN
  • Publication number: 20140194705
    Abstract: An evaluation of heart failure status is provided based on a disordered breathing index. Patient respiration is sensed and a respiration signal is generated. Disordered breathing episodes are detected based on the respiration signal. A disordered breathing index is determined based on the disordered breathing episodes. The disordered breathing index is trended and used to evaluate heart failure status. The disordered breathing index may be combined with additional information and/or may take into account patient activity, posture, sleep stage, or other patient information.
    Type: Application
    Filed: March 12, 2014
    Publication date: July 10, 2014
    Applicant: Cardiac Pacemakers, Inc.
    Inventors: Jonathan T. Kwok, Marina Brockway, Kent Lee, Quan Ni, Yachuan Pu, Jeffrey E. Stahmann, Yi Zhang, Jesse W. Hartley
  • Patent number: 8740789
    Abstract: A system and related method for identifying a trigger event to a patient health-related exacerbation. The system includes at least one sensor configured to collect data related to the patient health-related exacerbation, an analyzer configured to validate the collected data, a patient interface device configured to receive patient inputs to at least one question, and an identifier device configured to receive the patient inputs and collected data and identify the trigger event. The system may also include an expert system configured to receive the patient inputs and the validated collected data and identify a primary patient disease, and a reporting device configured to generate reports related to the identified primary patient disease, patient inputs, and sensed patient conditions.
    Type: Grant
    Filed: March 3, 2005
    Date of Patent: June 3, 2014
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Marina Brockway, David Johnson, Don Goscha, Veerichetty A. Kadhiresan, Muralidharan Srivathsa, Lisa Haeder
  • Publication number: 20140136585
    Abstract: Physiological signals are denoised. In accordance with an example embodiment, a denoised physiological signal is generated from an input signal including a desired physiological signal and noise. The input signal is decomposed from a first domain into subcomponents in a second domain of higher dimension than the first domain. Target subcomponents of the input signal that are associated with the desired physiological signal are identified, based upon the spatial distribution of the subcomponents. A denoised physiological signal is constructed in the first domain from at least one of the identified target subcomponents.
    Type: Application
    Filed: January 15, 2014
    Publication date: May 15, 2014
    Applicant: VivaQuant LLC
    Inventor: Marina Brockway
  • Patent number: 8696589
    Abstract: An evaluation of heart failure status is provided based on a disordered breathing index. Patient respiration is sensed and a respiration signal is generated. Disordered breathing episodes are detected based on the respiration signal. A disordered breathing index is determined based on the disordered breathing episodes. The disordered breathing index is trended and used to evaluate heart failure status. The disordered breathing index may be combined with additional information and/or may take into account patient activity, posture, sleep stage, or other patient information.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: April 15, 2014
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Jonathan T. Kwok, Marina Brockway, Kent Lee, Quan Ni, Yachuan Pu, Jeffrey E. Stahmann, Yi Zhang, Jesse W. Hartley
  • Patent number: 8688202
    Abstract: A cardiac-based metric is computed based upon characteristics of a subject's cardiac function. In accordance with one or more embodiments, the end of a mechanical systole is identified for each of a plurality of cardiac cycles of a subject, based upon an acoustical vibration associated with closure of an aortic valve during the cardiac cycle. The end of an electrical systole of an electrocardiogram (ECG) signal for each cardiac cycle is also identified. A cardiac-based metric is computed, based upon a time difference between the end of the electrical systole and the end of the mechanical systole, for the respective cardiac cycles.
    Type: Grant
    Filed: November 5, 2012
    Date of Patent: April 1, 2014
    Assignee: VivaQuant LLC
    Inventors: Marina Brockway, Brian Brockway, Robert Hamlin
  • Patent number: 8632465
    Abstract: Physiological signals are denoised. In accordance with an example embodiment, a denoised physiological signal is generated from an input signal including a desired physiological signal and noise. The input signal is decomposed from a first domain into subcomponents in a second domain of higher dimension than the first domain. Target subcomponents of the input signal that are associated with the desired physiological signal are identified, based upon the spatial distribution of the subcomponents. A denoised physiological signal is constructed in the first domain from at least one of the identified target subcomponents.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: January 21, 2014
    Assignee: VivaQuant LLC
    Inventor: Marina Brockway
  • Patent number: 8626276
    Abstract: Cardiac monitoring and/or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and/or trend ischemia using cardiac activation sequence information. Ischemia detection may involve sensing composite cardiac signals using implantable electrodes, and performing a signal separation that produces one or more cardiac activation signal vectors associated with one or more cardiac activation sequences. A change in the signal vector may be detected using subsequent separations. The change may be an elevation or depression of the ST segment of a cardiac cycle or other change indicative of myocardial ischemia, myocardial infarction, or other pathological change. The change may be used to predict, quantify, and/or qualify an event such as an arrhythmia, a myocardial infarction, or other pathologic change. Information associated with the vectors may be stored and used to track the vectors.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: January 7, 2014
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Yi Zhang, Scott A. Meyer, Jeffrey E. Stahmann, Carlos Alberto Ricci, Marina Brockway, Aaron R. McCabe, Yinghong Yu, Donald L. Hopper
  • Publication number: 20140005988
    Abstract: Physiological signals are denoised. In accordance with an example embodiment, a denoised physiological signal is generated from an input signal including a desired physiological signal and noise. The input signal is decomposed from a first domain into subcomponents in a second domain of higher dimension than the first domain. Target subcomponents of the input signal that are associated with the desired physiological signal are identified, based upon the spatial distribution of the subcomponents. A denoised physiological signal is constructed in the first domain from at least one of the identified target subcomponents.
    Type: Application
    Filed: November 3, 2010
    Publication date: January 2, 2014
    Inventor: Marina Brockway